Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Michele Fox

Concepts (432)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation
31
2017
533
2.370
 Why?
Hematopoietic Stem Cells
21
2018
231
2.140
 Why?
Bone Marrow Transplantation
28
2016
164
2.120
 Why?
Multiple Myeloma
44
2018
2750
2.070
 Why?
Hematopoietic Stem Cell Mobilization
14
2018
64
1.820
 Why?
Antigens, CD34
21
2018
83
1.160
 Why?
Antineoplastic Combined Chemotherapy Protocols
15
2016
1025
0.930
 Why?
Cell Separation
8
2013
115
0.920
 Why?
Blood Platelets
5
2017
306
0.890
 Why?
Purpura, Thrombotic Thrombocytopenic
3
2018
19
0.820
 Why?
Transplantation, Autologous
22
2013
463
0.710
 Why?
Melphalan
7
2016
178
0.690
 Why?
Graft vs Host Disease
16
2003
84
0.690
 Why?
Leukapheresis
5
2018
15
0.680
 Why?
Blood Component Removal
5
2018
19
0.630
 Why?
Myelodysplastic Syndromes
3
2013
82
0.630
 Why?
Leukocytes, Mononuclear
5
2018
140
0.560
 Why?
Fetal Blood
3
2019
58
0.550
 Why?
Plasma Exchange
3
2015
34
0.550
 Why?
Adult
49
2019
14316
0.520
 Why?
Middle Aged
44
2018
13614
0.500
 Why?
Humans
88
2019
52865
0.500
 Why?
Aged
33
2017
10428
0.460
 Why?
Transplantation Conditioning
9
2006
86
0.460
 Why?
Flow Cytometry
6
2016
582
0.460
 Why?
Killer Cells, Natural
3
2015
109
0.450
 Why?
Granulocyte Colony-Stimulating Factor
7
2012
66
0.450
 Why?
Immunotherapy, Adoptive
2
2015
84
0.420
 Why?
Transplantation, Homologous
14
2016
162
0.420
 Why?
Chromosome Aberrations
5
2016
310
0.410
 Why?
Female
50
2019
28888
0.390
 Why?
Male
48
2019
28240
0.390
 Why?
Platelet Count
4
2017
66
0.390
 Why?
Cell Proliferation
5
2018
1124
0.390
 Why?
Blood Transfusion
3
2017
130
0.380
 Why?
Antigens, CD
10
2003
263
0.370
 Why?
Thalidomide
5
2016
401
0.370
 Why?
Blood Specimen Collection
1
2019
39
0.360
 Why?
Blood Volume
1
2019
74
0.360
 Why?
Antibodies
2
2016
175
0.350
 Why?
Education, Distance
1
2019
41
0.350
 Why?
Cryopreservation
3
2010
36
0.340
 Why?
Clinical Laboratory Techniques
1
2018
31
0.340
 Why?
Lymphoma
3
2018
62
0.340
 Why?
Erythrocyte Transfusion
3
2015
88
0.330
 Why?
Graft Survival
8
2011
169
0.330
 Why?
Cyclooxygenase Inhibitors
1
2017
45
0.330
 Why?
Obstetrics
1
2019
92
0.330
 Why?
Blood Grouping and Crossmatching
1
2017
6
0.320
 Why?
Leukemia
3
2013
77
0.320
 Why?
Blood Coagulation
1
2017
79
0.320
 Why?
Leukocytes
3
2011
95
0.310
 Why?
Bone Marrow Cells
5
2004
245
0.300
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
2000
48
0.290
 Why?
Aspirin
1
2017
133
0.290
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
151
0.290
 Why?
Platelet Aggregation Inhibitors
1
2017
209
0.280
 Why?
Hemoglobins, Abnormal
1
2015
4
0.280
 Why?
Heparin
1
2015
101
0.270
 Why?
Thrombocytopenia
1
2015
94
0.270
 Why?
Combined Modality Therapy
12
2014
713
0.270
 Why?
Stem Cell Transplantation
2
2013
193
0.270
 Why?
Factor VIII
1
2014
23
0.270
 Why?
Methotrexate
2
2001
75
0.260
 Why?
ADAM Proteins
1
2014
26
0.260
 Why?
Anemia, Sickle Cell
1
2015
99
0.250
 Why?
Retroviridae
4
1997
12
0.240
 Why?
Retrospective Studies
11
2018
6065
0.240
 Why?
Neoplasm Recurrence, Local
3
2015
596
0.240
 Why?
Dendritic Cells
3
2010
151
0.240
 Why?
Cancer Vaccines
3
2010
106
0.240
 Why?
Internship and Residency
1
2019
493
0.240
 Why?
Cell Count
7
2011
195
0.240
 Why?
Prognosis
8
2018
2104
0.240
 Why?
Cytomegalovirus Infections
3
2001
45
0.240
 Why?
Antiretroviral Therapy, Highly Active
1
2013
41
0.240
 Why?
Afibrinogenemia
1
2012
5
0.230
 Why?
Graft vs Tumor Effect
2
2006
3
0.230
 Why?
Cell Survival
7
2011
693
0.220
 Why?
Bone Marrow
8
1997
413
0.220
 Why?
Leukemia, Myeloid
2
2000
59
0.220
 Why?
Adenoviridae Infections
1
2001
5
0.220
 Why?
Aldehyde Dehydrogenase
1
2011
28
0.220
 Why?
Gene Transfer Techniques
3
1997
43
0.220
 Why?
Lung Diseases, Fungal
1
2001
33
0.220
 Why?
Tamoxifen
1
2001
69
0.210
 Why?
Treatment Outcome
19
2013
5631
0.210
 Why?
Follow-Up Studies
10
2013
2447
0.210
 Why?
Cyclophosphamide
8
2006
190
0.210
 Why?
Plateletpheresis
1
2010
8
0.210
 Why?
Pyrazines
2
2013
204
0.210
 Why?
Boronic Acids
2
2013
200
0.210
 Why?
Blood Preservation
1
2010
31
0.200
 Why?
Lymphoma, B-Cell
1
2000
66
0.200
 Why?
Myeloablative Agonists
3
2007
35
0.200
 Why?
Blood Proteins
1
2010
104
0.200
 Why?
Peripheral Blood Stem Cell Transplantation
3
2006
58
0.190
 Why?
Anaphylaxis
1
2010
71
0.190
 Why?
Fever
1
2001
122
0.190
 Why?
Immunosuppressive Agents
4
2014
256
0.190
 Why?
Chromosomes, Human, Pair 1
2
2007
100
0.190
 Why?
Genetic Vectors
4
1997
150
0.190
 Why?
Blood Cells
4
1994
57
0.180
 Why?
Incidence
7
2017
1088
0.180
 Why?
Receptors, KIR
1
2008
16
0.180
 Why?
Etoposide
6
2006
89
0.180
 Why?
HIV Infections
1
2013
389
0.170
 Why?
Gene Expression Regulation, Neoplastic
2
2016
896
0.160
 Why?
Disease-Free Survival
6
2016
518
0.160
 Why?
Phosphotransferases (Alcohol Group Acceptor)
2
1995
23
0.160
 Why?
Immunoglobulins, Intravenous
3
1992
58
0.160
 Why?
CD8-Positive T-Lymphocytes
2
2001
111
0.160
 Why?
Cell Movement
2
2006
301
0.160
 Why?
Lymphocyte Transfusion
3
2003
13
0.160
 Why?
CD4-Positive T-Lymphocytes
2
2001
188
0.150
 Why?
Models, Genetic
1
2006
204
0.150
 Why?
Transformation, Genetic
1
1995
19
0.150
 Why?
Breast Neoplasms
6
1995
1272
0.150
 Why?
Risk Factors
7
2015
3984
0.140
 Why?
Osteogenesis
2
2006
378
0.140
 Why?
Models, Statistical
1
2007
267
0.140
 Why?
Young Adult
4
2019
4295
0.140
 Why?
Antineoplastic Agents
5
2012
1290
0.140
 Why?
Metaphase
3
2016
57
0.140
 Why?
Dimethyl Sulfoxide
2
2010
14
0.140
 Why?
Mycobacterium tuberculosis
1
2007
236
0.140
 Why?
Lymphocytes, Tumor-Infiltrating
1
1995
81
0.140
 Why?
Macrophages
1
2018
413
0.130
 Why?
Gene Expression Profiling
2
2007
1118
0.130
 Why?
Recurrence
4
2008
694
0.130
 Why?
Cytokines
2
2006
700
0.130
 Why?
Enzyme-Linked Immunosorbent Assay
2
2015
318
0.130
 Why?
Immunoglobulin G
3
2003
229
0.130
 Why?
Risk
2
2017
361
0.130
 Why?
Acute Disease
4
2013
417
0.130
 Why?
Time Factors
2
2010
3434
0.130
 Why?
Postoperative Complications
2
2001
1083
0.130
 Why?
Cytotoxicity Tests, Immunologic
2
2016
30
0.120
 Why?
Models, Biological
2
2007
872
0.120
 Why?
Sweet Syndrome
1
2003
14
0.120
 Why?
Dexamethasone
5
2007
397
0.120
 Why?
Neoplasms
4
2007
1258
0.120
 Why?
T-Lymphocyte Subsets
2
2001
45
0.120
 Why?
Bone Diseases
1
2004
107
0.120
 Why?
Cyclosporine
1
2003
71
0.120
 Why?
Tacrolimus
1
2003
50
0.110
 Why?
Osteoblasts
1
2006
535
0.110
 Why?
Prospective Studies
6
2016
2453
0.110
 Why?
Blood Group Incompatibility
1
2002
4
0.110
 Why?
ABO Blood-Group System
1
2002
14
0.110
 Why?
Hemorrhage
2
2017
197
0.110
 Why?
Coculture Techniques
3
2018
163
0.110
 Why?
Kaplan-Meier Estimate
3
2007
535
0.110
 Why?
Genetic Therapy
3
1995
117
0.110
 Why?
T-Lymphocytes
2
1998
340
0.110
 Why?
Cryoprotective Agents
2
1998
5
0.110
 Why?
Ovarian Neoplasms
1
1995
447
0.110
 Why?
Lymphoma, Mantle-Cell
2
2001
19
0.100
 Why?
Hodgkin Disease
2
2002
49
0.100
 Why?
Platelet Transfusion
2
2010
34
0.100
 Why?
Lymphocyte Depletion
3
1996
13
0.100
 Why?
Osteoclasts
1
2004
461
0.100
 Why?
Tissue Preservation
2
1998
8
0.100
 Why?
Cyclosporins
2
1991
11
0.100
 Why?
Tissue Donors
3
2003
105
0.100
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
3
2012
77
0.100
 Why?
T-Lymphocytes, Cytotoxic
1
2010
76
0.100
 Why?
Heart Failure
1
2006
548
0.100
 Why?
Lung Diseases
1
2001
99
0.100
 Why?
Vaccines, DNA
1
1999
23
0.100
 Why?
Thrombosis
1
2003
263
0.090
 Why?
Erythroid Precursor Cells
1
2019
19
0.090
 Why?
Blood Banks
1
2019
18
0.090
 Why?
Adolescent
6
2015
6866
0.090
 Why?
Birth Weight
1
2019
113
0.090
 Why?
Logistic Models
3
2017
1028
0.090
 Why?
Reproducibility of Results
3
2017
1326
0.090
 Why?
Graft vs Host Reaction
1
1998
2
0.090
 Why?
Salvage Therapy
3
2003
146
0.090
 Why?
Hematocrit
1
2018
53
0.090
 Why?
Cisplatin
4
2006
348
0.090
 Why?
Antigens, Neoplasm
2
2005
170
0.080
 Why?
Cell Aggregation
1
2017
8
0.080
 Why?
Medical Waste
1
2017
4
0.080
 Why?
Antineoplastic Agents, Alkylating
2
2008
77
0.080
 Why?
Survival Analysis
6
2006
791
0.080
 Why?
Neutrophils
2
2006
162
0.080
 Why?
Lymphoma, Follicular
1
2017
26
0.080
 Why?
Histocompatibility Antigens Class I
1
2017
47
0.080
 Why?
Lung
1
2001
489
0.080
 Why?
Program Evaluation
1
2019
403
0.080
 Why?
Arkansas
2
2017
2175
0.080
 Why?
Lymphocyte Activation
2
1995
212
0.080
 Why?
Infant, Newborn
2
2019
2767
0.080
 Why?
Neoplasm Proteins
2
2016
387
0.080
 Why?
Fibrosis
1
2017
216
0.080
 Why?
Reticulocyte Count
1
2006
7
0.070
 Why?
Tumor Escape
1
2006
23
0.070
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2017
102
0.070
 Why?
Antibodies, Monoclonal
2
2002
562
0.070
 Why?
Glucosylceramidase
1
1995
11
0.070
 Why?
Curriculum
1
2019
417
0.070
 Why?
Prostatic Neoplasms
1
1999
413
0.070
 Why?
Dose-Response Relationship, Drug
3
2008
1571
0.070
 Why?
Cytogenetic Analysis
2
2007
79
0.070
 Why?
Neutropenia
1
2006
117
0.070
 Why?
Hematologic Neoplasms
1
1996
89
0.070
 Why?
Hemoglobin J
1
2015
3
0.070
 Why?
Hemoglobin, Sickle
1
2015
7
0.070
 Why?
Hemoglobin C
1
2015
7
0.070
 Why?
Membrane Glycoproteins
3
2004
295
0.070
 Why?
Mice
5
2018
6389
0.070
 Why?
Blood Donors
1
2015
40
0.070
 Why?
Clinical Protocols
2
2012
128
0.070
 Why?
Tumor Necrosis Factor-alpha
2
2007
445
0.060
 Why?
Diagnosis, Differential
1
2018
1184
0.060
 Why?
Autoantibodies
1
2014
123
0.060
 Why?
Aged, 80 and over
3
2013
3624
0.060
 Why?
Specimen Handling
1
1994
63
0.060
 Why?
Feasibility Studies
2
2011
403
0.060
 Why?
Cell Line
2
2008
1226
0.060
 Why?
Base Sequence
3
1995
773
0.060
 Why?
Prednisone
2
2000
116
0.060
 Why?
CD4 Lymphocyte Count
1
2013
36
0.060
 Why?
Interferon-gamma
2
2010
201
0.060
 Why?
Age Factors
3
2005
1262
0.060
 Why?
Whole-Body Irradiation
4
1998
163
0.060
 Why?
Blotting, Western
1
2015
721
0.060
 Why?
Multivariate Analysis
3
2007
698
0.060
 Why?
Pulmonary Fibrosis
2
1991
22
0.060
 Why?
Molecular Sequence Data
3
1995
1053
0.060
 Why?
Viral Load
1
2013
87
0.060
 Why?
Quality Assurance, Health Care
1
1994
169
0.060
 Why?
Transplantation Chimera
3
2003
17
0.060
 Why?
Pharmacokinetics
1
1992
17
0.060
 Why?
Immunization, Passive
1
1992
36
0.060
 Why?
Bone Marrow Purging
1
1992
2
0.060
 Why?
Benzylamines
1
2012
19
0.060
 Why?
Receptors, CXCR4
1
2012
33
0.060
 Why?
Haplotypes
2
2008
110
0.060
 Why?
Heterocyclic Compounds
1
2012
31
0.060
 Why?
Animals
6
2018
14801
0.060
 Why?
Immunoglobulins
1
1992
87
0.060
 Why?
Infection Control
1
1992
58
0.060
 Why?
Kanamycin Kinase
2
1995
2
0.050
 Why?
Carmustine
1
2001
13
0.050
 Why?
Cohort Studies
3
2006
1532
0.050
 Why?
Pneumonia, Pneumocystis
1
2001
7
0.050
 Why?
Urine
1
1991
37
0.050
 Why?
Pregnancy
1
2019
2432
0.050
 Why?
Lymphoma, Non-Hodgkin
1
2002
61
0.050
 Why?
Microscopy, Electron
1
2001
98
0.050
 Why?
Recombinant Proteins
2
2008
594
0.050
 Why?
Immunohistochemistry
1
2015
1140
0.050
 Why?
Child
5
2015
6934
0.050
 Why?
Foscarnet
1
2001
4
0.050
 Why?
Immune Tolerance
1
2011
104
0.050
 Why?
DNA Primers
2
1995
242
0.050
 Why?
Ganciclovir
1
2001
37
0.050
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2000
8
0.050
 Why?
Cytomegalovirus
1
2001
29
0.050
 Why?
Quality Control
3
2005
98
0.050
 Why?
Chimera
1
1990
14
0.050
 Why?
Tumor Cells, Cultured
2
1996
528
0.050
 Why?
Isotonic Solutions
1
2010
22
0.050
 Why?
Virus Activation
1
2001
29
0.050
 Why?
P-Selectin
1
2010
43
0.050
 Why?
Anemia, Aplastic
1
1990
12
0.050
 Why?
Antigens, Viral
1
2001
57
0.050
 Why?
Fatal Outcome
1
2001
234
0.050
 Why?
Syndrome
1
2001
259
0.050
 Why?
Sodium Chloride
1
2010
68
0.050
 Why?
Neovascularization, Pathologic
1
2001
175
0.050
 Why?
Platelet Aggregation
1
2010
93
0.050
 Why?
Transfection
3
1999
439
0.050
 Why?
Platelet Activation
1
2010
67
0.050
 Why?
Angiogenesis Inhibitors
2
2007
215
0.050
 Why?
Hypersensitivity
1
2010
74
0.050
 Why?
Algorithms
2
2005
729
0.050
 Why?
Polyomavirus
1
1989
5
0.050
 Why?
Peripheral Nervous System Diseases
1
1990
61
0.050
 Why?
Leukemia, Myeloid, Acute
2
2007
172
0.050
 Why?
Predictive Value of Tests
2
2007
1067
0.050
 Why?
Cystitis
1
1989
21
0.050
 Why?
Antiviral Agents
1
2001
185
0.050
 Why?
Ultraviolet Rays
1
1989
56
0.050
 Why?
Polymerase Chain Reaction
2
1995
556
0.040
 Why?
Clone Cells
2
2006
86
0.040
 Why?
Arginase
1
2018
33
0.040
 Why?
Nitric Oxide Synthase Type II
1
2018
84
0.040
 Why?
Glucocorticoids
1
2000
285
0.040
 Why?
Ligands
1
2008
254
0.040
 Why?
Hemoglobins
1
2008
124
0.040
 Why?
Polyethylene Glycols
1
2008
98
0.040
 Why?
Pilot Projects
1
2000
805
0.040
 Why?
Carrier Proteins
2
2004
377
0.040
 Why?
DNA
1
1991
586
0.040
 Why?
Age Distribution
1
2007
210
0.040
 Why?
Antineoplastic Agents, Hormonal
1
2007
54
0.040
 Why?
Theophylline
1
2007
22
0.040
 Why?
Multigene Family
1
2006
67
0.040
 Why?
Chromosome Deletion
1
2007
150
0.040
 Why?
Chromosome Mapping
1
2006
175
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2007
273
0.040
 Why?
3T3 Cells
1
1995
58
0.040
 Why?
Cytotoxicity, Immunologic
1
1995
63
0.040
 Why?
Interleukin-2
1
1995
82
0.040
 Why?
Cell Communication
1
2006
73
0.040
 Why?
Interleukin-10
1
2006
108
0.040
 Why?
Neoplasms, Experimental
1
2006
119
0.030
 Why?
Life Tables
2
2002
9
0.030
 Why?
Stroke Volume
1
2006
139
0.030
 Why?
Apoptosis
1
2001
1357
0.030
 Why?
Ventricular Dysfunction, Left
1
2006
103
0.030
 Why?
Ficoll
2
1996
4
0.030
 Why?
Liver
1
2001
1266
0.030
 Why?
Annexin A5
1
2004
15
0.030
 Why?
Receptor Activator of Nuclear Factor-kappa B
1
2004
38
0.030
 Why?
Bromodeoxyuridine
1
2004
22
0.030
 Why?
Databases, Factual
1
2007
698
0.030
 Why?
Culture Media, Conditioned
1
2004
52
0.030
 Why?
Phagocytosis
1
2004
48
0.030
 Why?
Myocardial Ischemia
1
2006
150
0.030
 Why?
Immunotherapy
2
2002
248
0.030
 Why?
Survival Rate
1
2006
1012
0.030
 Why?
Mice, Transgenic
1
2006
725
0.030
 Why?
Syndecans
1
2003
46
0.030
 Why?
Fluorescent Antibody Technique, Indirect
1
2003
30
0.030
 Why?
Paraproteins
1
2003
13
0.030
 Why?
Ifosfamide
2
1993
7
0.030
 Why?
Syndecan-1
1
2003
82
0.030
 Why?
Plasmapheresis
1
2003
14
0.030
 Why?
Cell Division
1
2004
369
0.030
 Why?
Proteoglycans
1
2003
97
0.030
 Why?
Immunoenzyme Techniques
1
2003
173
0.030
 Why?
Chronic Disease
1
2006
625
0.030
 Why?
RANK Ligand
1
2004
189
0.030
 Why?
Remission Induction
2
2003
223
0.030
 Why?
Interleukin-6
1
2004
318
0.030
 Why?
Red-Cell Aplasia, Pure
1
2002
9
0.030
 Why?
Infusions, Intravenous
2
2003
245
0.030
 Why?
Blood Transfusion, Autologous
2
1992
7
0.030
 Why?
Drug Administration Schedule
2
2003
425
0.030
 Why?
NF-kappa B
1
2004
350
0.030
 Why?
Severity of Illness Index
1
2006
1113
0.030
 Why?
Gene Rearrangement, T-Lymphocyte
1
2001
2
0.030
 Why?
Lymphocyte Count
1
2001
26
0.030
 Why?
Bronchoalveolar Lavage Fluid
1
2001
44
0.030
 Why?
Graft Rejection
1
2002
163
0.030
 Why?
Colony-Forming Units Assay
2
1992
34
0.030
 Why?
CD40 Ligand
1
2010
18
0.030
 Why?
Drug Resistance, Neoplasm
2
2003
297
0.030
 Why?
Immunoglobulin Idiotypes
1
2010
18
0.030
 Why?
Hypersensitivity, Delayed
1
2010
21
0.030
 Why?
Cell Differentiation
1
2004
757
0.030
 Why?
Interleukin-4
1
2010
51
0.030
 Why?
Immunity, Cellular
1
2010
85
0.020
 Why?
Adjuvants, Immunologic
1
2010
64
0.020
 Why?
Disease Models, Animal
1
2006
1693
0.020
 Why?
Biotechnology
1
1999
16
0.020
 Why?
Immunologic Surveillance
1
1999
18
0.020
 Why?
B-Lymphocytes
1
2010
187
0.020
 Why?
Child, Preschool
3
1994
4140
0.020
 Why?
Magnetic Resonance Imaging
1
2007
1710
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2001
712
0.020
 Why?
Transcription, Genetic
1
2001
465
0.020
 Why?
Vaccination
1
2010
213
0.020
 Why?
Drug Resistance
1
1998
80
0.020
 Why?
Steroids
1
1998
56
0.020
 Why?
Chromatography, Gas
1
1998
21
0.020
 Why?
Neomycin
1
1997
4
0.020
 Why?
Secondary Prevention
1
1998
88
0.020
 Why?
Drug Resistance, Microbial
1
1997
45
0.020
 Why?
Leukemia, Erythroblastic, Acute
1
1996
6
0.020
 Why?
Centrifugation, Density Gradient
1
1996
25
0.020
 Why?
Solutions
1
1996
30
0.020
 Why?
Indicators and Reagents
1
1996
58
0.020
 Why?
Stromal Cells
1
1997
98
0.020
 Why?
Deoxycytidine
1
2006
30
0.020
 Why?
Temperature
1
1996
176
0.020
 Why?
Genes
1
1995
40
0.020
 Why?
Transduction, Genetic
1
1995
52
0.020
 Why?
In Situ Hybridization
1
1995
88
0.020
 Why?
Chromatography, Affinity
1
1995
48
0.020
 Why?
Genes, Reporter
1
1995
116
0.020
 Why?
Fluorouracil
1
1995
74
0.020
 Why?
Genetic Markers
1
1995
124
0.020
 Why?
Lymphocyte Subsets
1
1994
19
0.020
 Why?
Recovery of Function
1
2006
236
0.020
 Why?
Mice, Inbred BALB C
1
1995
380
0.020
 Why?
Propidium
1
1994
3
0.020
 Why?
Macaca mulatta
1
1994
113
0.020
 Why?
Kinetics
1
2006
740
0.020
 Why?
Immunophenotyping
1
1994
128
0.020
 Why?
Oligodeoxyribonucleotides
1
1993
33
0.020
 Why?
Stem Cell Factor
1
2003
8
0.020
 Why?
Confidence Intervals
1
2003
177
0.020
 Why?
Probability
1
2003
186
0.020
 Why?
Cell Nucleus
1
1994
220
0.010
 Why?
Leukocyte Count
1
2003
81
0.010
 Why?
Data Interpretation, Statistical
1
1994
185
0.010
 Why?
Cell Death
1
1994
238
0.010
 Why?
Carboplatin
1
1992
54
0.010
 Why?
Academic Medical Centers
1
1994
155
0.010
 Why?
Mutation
1
1999
1428
0.010
 Why?
Multiple Organ Failure
1
2002
56
0.010
 Why?
Leukopenia
1
1992
10
0.010
 Why?
Neoplasm Metastasis
1
1993
263
0.010
 Why?
Injections, Intravenous
1
1992
161
0.010
 Why?
Statistics as Topic
1
1992
108
0.010
 Why?
Blood Cell Count
1
1992
43
0.010
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2002
54
0.010
 Why?
Administration, Oral
1
2003
481
0.010
 Why?
Rats
1
1998
3599
0.010
 Why?
Doxorubicin
1
2003
266
0.010
 Why?
Linear Models
1
1992
322
0.010
 Why?
Proportional Hazards Models
1
1992
458
0.010
 Why?
HLA Antigens
1
1990
53
0.010
 Why?
Pedigree
1
1990
140
0.010
 Why?
Muscle Cramp
1
1990
5
0.010
 Why?
Neoplasm Staging
1
2003
809
0.010
 Why?
Bacterial Infections
1
1991
105
0.010
 Why?
Mycoses
1
1991
154
0.010
 Why?
Postoperative Period
1
1990
200
0.010
 Why?
Software
1
1992
281
0.010
 Why?
Busulfan
1
1989
18
0.010
 Why?
Disease Progression
1
2003
898
0.010
 Why?
Sepsis
1
2002
239
0.010
 Why?
Tumor Virus Infections
1
1989
44
0.010
 Why?
Hematopoiesis
1
1989
85
0.010
 Why?
Dose-Response Relationship, Radiation
1
1989
213
0.010
 Why?
Infant
1
1990
3694
0.010
 Why?
Fox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (432) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department